305 related articles for article (PubMed ID: 7548060)
21. Determination of kinetic constants for peptidyl prolyl cis-trans isomerases by an improved spectrophotometric assay.
Kofron JL; Kuzmic P; Kishore V; Colón-Bonilla E; Rich DH
Biochemistry; 1991 Jun; 30(25):6127-34. PubMed ID: 2059621
[TBL] [Abstract][Full Text] [Related]
22. Crystal structure implies that cyclophilin predominantly catalyzes the trans to cis isomerization.
Zhao Y; Ke H
Biochemistry; 1996 Jun; 35(23):7356-61. PubMed ID: 8652511
[TBL] [Abstract][Full Text] [Related]
23. Thermodynamics of cyclophilin catalyzed peptidyl-prolyl isomerization by NMR spectroscopy.
Videen JS; Stamnes MA; Hsu VL; Goodman M
Biopolymers; 1994 Feb; 34(2):171-5. PubMed ID: 8142586
[TBL] [Abstract][Full Text] [Related]
24. [Determination of enzymatic catalysis for the cis-trans-isomerization of peptide binding in proline-containing peptides].
Fischer G; Bang H; Mech C
Biomed Biochim Acta; 1984; 43(10):1101-11. PubMed ID: 6395866
[TBL] [Abstract][Full Text] [Related]
25. Mapping the stereospecificity of peptidyl prolyl cis/trans isomerases.
Schiene C; Reimer U; Schutkowski M; Fischer G
FEBS Lett; 1998 Aug; 432(3):202-6. PubMed ID: 9720925
[TBL] [Abstract][Full Text] [Related]
26. Thioxo amino acid pyrrolidides and thiazolidides: new inhibitors of proline specific peptidases.
Stöckel-Maschek A; Mrestani-Klaus C; Stiebitz B; Demuth H; Neubert K
Biochim Biophys Acta; 2000 Jun; 1479(1-2):15-31. PubMed ID: 11004527
[TBL] [Abstract][Full Text] [Related]
27. Crystal structure of cyclophilin A complexed with substrate Ala-Pro suggests a solvent-assisted mechanism of cis-trans isomerization.
Ke H; Mayrose D; Cao W
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3324-8. PubMed ID: 8475075
[TBL] [Abstract][Full Text] [Related]
28. An 11.8 kDa proteolytic fragment of the E. coli trigger factor represents the domain carrying the peptidyl-prolyl cis/trans isomerase activity.
Stoller G; Tradler T; Rücknagel KP; Rahfeld J-U ; Fischer G
FEBS Lett; 1996 Apr; 384(2):117-22. PubMed ID: 8612805
[TBL] [Abstract][Full Text] [Related]
29. Peptidyl-prolyl cis-trans-isomerase from Escherichia coli: a periplasmic homolog of cyclophilin that is not inhibited by cyclosporin A.
Liu J; Walsh CT
Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4028-32. PubMed ID: 2190212
[TBL] [Abstract][Full Text] [Related]
30. Side-chain effects on peptidyl-prolyl cis/trans isomerisation.
Reimer U; Scherer G; Drewello M; Kruber S; Schutkowski M; Fischer G
J Mol Biol; 1998 Jun; 279(2):449-60. PubMed ID: 9642049
[TBL] [Abstract][Full Text] [Related]
31. The rate of isomerisation of peptidyl-proline bonds as a probe for interactions in the physiological denatured state of chymotrypsin inhibitor 2.
Tan YJ; Oliveberg M; Otzen DE; Fersht AR
J Mol Biol; 1997 Jun; 269(4):611-22. PubMed ID: 9217264
[TBL] [Abstract][Full Text] [Related]
32. A ribosome-associated peptidyl-prolyl cis/trans isomerase identified as the trigger factor.
Stoller G; Rücknagel KP; Nierhaus KH; Schmid FX; Fischer G; Rahfeld JU
EMBO J; 1995 Oct; 14(20):4939-48. PubMed ID: 7588623
[TBL] [Abstract][Full Text] [Related]
33. The N-terminal cyclophilin-homologous domain of a 150-kilodalton tumor recognition molecule exhibits both peptidylprolyl cis-trans-isomerase and chaperone activities.
Rinfret A; Collins C; Ménard R; Anderson SK
Biochemistry; 1994 Feb; 33(7):1668-73. PubMed ID: 7906541
[TBL] [Abstract][Full Text] [Related]
34. Role of phosphorylation in determining the backbone dynamics of the serine/threonine-proline motif and Pin1 substrate recognition.
Schutkowski M; Bernhardt A; Zhou XZ; Shen M; Reimer U; Rahfeld JU; Lu KP; Fischer G
Biochemistry; 1998 Apr; 37(16):5566-75. PubMed ID: 9548941
[TBL] [Abstract][Full Text] [Related]
35. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
Dreyer GB; Lambert DM; Meek TD; Carr TJ; Tomaszek TA; Fernandez AV; Bartus H; Cacciavillani E; Hassell AM; Minnich M
Biochemistry; 1992 Jul; 31(29):6646-59. PubMed ID: 1637805
[TBL] [Abstract][Full Text] [Related]
36. Cyclophilin active site mutants have native prolyl isomerase activity with a protein substrate.
Scholz C; Schindler T; Dolinski K; Heitman J; Schmid FX
FEBS Lett; 1997 Sep; 414(1):69-73. PubMed ID: 9305734
[TBL] [Abstract][Full Text] [Related]
37. Oligopeptide cyclophilin inhibitors: a reassessment.
Schumann M; Jahreis G; Kahlert V; Lücke C; Fischer G
Eur J Med Chem; 2011 Nov; 46(11):5556-61. PubMed ID: 21963115
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and evaluation of Glypsi(PO(2)R-N)Pro-containing pseudopeptides as novel inhibitors of the human cyclophilin hCyp-18.
Demange L; Moutiez M; Dugave C
J Med Chem; 2002 Aug; 45(18):3928-33. PubMed ID: 12190314
[TBL] [Abstract][Full Text] [Related]
39. Unexpectedly fast cis/trans isomerization of Xaa-Pro peptide bonds in disulfide-constrained cyclic peptides.
Shi T; Spain SM; Rabenstein DL
J Am Chem Soc; 2004 Jan; 126(3):790-6. PubMed ID: 14733553
[TBL] [Abstract][Full Text] [Related]
40. PPIase catalysis by human FK506-binding protein proceeds through a conformational twist mechanism.
Park ST; Aldape RA; Futer O; DeCenzo MT; Livingston DJ
J Biol Chem; 1992 Feb; 267(5):3316-24. PubMed ID: 1371117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
